Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kazuki Ohno
Observed names:
K Ohno,
K. Ohno
Institutions:
Tokyo Institute of Technology,
Astellas Pharma (Japan)
Observed institutions:
Tokyo Institute of Technology,
Astellas Pharma (Japan),
Meiji University,
Japan Biological Informatics Consortium,
National Institute of Advanced Industrial Science and Technology
OpenAlex ID:
A5028778330
Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase
2016
·
Motomichi Kosuga
, Ryuichi Mashima
, et al.
·
Molecular Genetics and Metabolism
·
82
Therapeutic Potential of Intracerebroventricular Replacement of Modified Human β-Hexosaminidase B for GM2 Gangliosidosis
2011
·
Kazuhiko Matsuoka
, Tomomi Tamura
, et al.
·
Molecular Therapy
·
74
PDF
Fabry-database.org: database of the clinical phenotypes, genotypes and mutant α-galactosidase A structures in Fabry disease
2011
·
Seiji Saito
, Kazuki Ohno
, et al.
·
Journal of Human Genetics
·
70
Structural basis for telmisartan-mediated partial activation of PPAR gamma
2012
·
Yasushi Amano
, Tomohiko Yamaguchi
, et al.
·
Hypertension Research
·
67
PDF
Computational Insights into Binding of Bisphosphates to Farnesyl Pyrophosphate Synthase
2011
·
K. Ohno
, K. Mori
, et al.
·
Current Medicinal Chemistry
·
67
PDF
Two ‘Golden Ratio’ indices in fragment-based drug discovery
2008
·
Masaya Orita
, Kazuki Ohno
, et al.
·
Drug Discovery Today
·
62
Use of a Modified α-N-Acetylgalactosaminidase in the Development of Enzyme Replacement Therapy for Fabry Disease
2009
·
Youichi Tajima
, Ikuo Kawashima
, et al.
·
The American Journal of Human Genetics
·
60
PDF
Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form
2013
·
Mohammad Arif Hossain
, Takanobu Otomo
, et al.
·
Gene
·
57
PDF
Fabry disease: Biochemical, pathological and structural studies of the α-galactosidase A with E66Q amino acid substitution
2012
·
Tadayasu Togawa
, Takahiro Tsukimura
, et al.
·
Molecular Genetics and Metabolism
·
52
Novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potent and orally active STAT6 inhibitors
2009
·
Shinya Nagashima
, Takeshi Hondo
, et al.
·
Bioorganic & Medicinal Chemistry
·
52
Human α- l -iduronidase uses its own N -glycan as a substrate-binding and catalytic module
2013
·
Nobuo Maita
, Takahiro Tsukimura
, et al.
·
Proceedings of the National Academy of Sciences
·
50
PDF
Identification, Synthesis, and Biological Evaluation of 6-[(6R)-2-(4-Fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2H)-one (AS1940477), a Potent p38 MAP Kinase Inhibitor
2012
·
Toru Asano
, Hitoshi Yamazaki
, et al.
·
Journal of Medicinal Chemistry
·
47
Lead Generation and Examples
2011
·
Masaya Orita
, Kazuki Ohno
, et al.
·
Methods in enzymology on CD-ROM/Methods in enzymology
·
47
Pharmacophore Modeling for Anti-Chagas Drug Design Using the Fragment Molecular Orbital Method
2015
·
Ryunosuke Yoshino
, Nobuaki Yasuo
, et al.
·
PLoS ONE
·
46
PDF
Binding parameters and thermodynamics of the interaction of imino sugars with a recombinant human acid α-glucosidase (alglucosidase alfa): Insight into the complex formation mechanism
2008
·
Michiru Yoshimizu
, Youichi Tajima
, et al.
·
Clinica Chimica Acta
·
44
Structural bases of Wolman disease and cholesteryl ester storage disease
2011
·
Seiji Saito
, Kazuki Ohno
, et al.
·
Molecular Genetics and Metabolism
·
43
Unique “delta lock” structure of telmisartan is involved in its strongest binding affinity to angiotensin II type 1 receptor
2010
·
Kazuki Ohno
, Yasushi Amano
, et al.
·
Biochemical and Biophysical Research Communications
·
43
Fabry disease in a Japanese population-molecular and biochemical characteristics
2018
·
Hitoshi Sakuraba
, Takahiro Tsukimura
, et al.
·
Molecular Genetics and Metabolism Reports
·
41
PDF
Molecular interaction of imino sugars with human α-galactosidase: Insight into the mechanism of complex formation and pharmacological chaperone action in Fabry disease
2009
·
Kanako Sugawara
, Youichi Tajima
, et al.
·
Molecular Genetics and Metabolism
·
41
Application of an integrated MOZYME+DFT method to pKa calculations for proteins
2001
·
K Ohno
, N Kamiya
, et al.
·
Chemical Physics Letters
·
38
Chaperone therapy for Krabbe disease: potential for late-onset GALC mutations
2015
·
Mohammad Arif Hossain
, Katsumi Higaki
, et al.
·
Journal of Human Genetics
·
35
Small-World Phenomena in Chemical Library Networks: Application to Fragment-Based Drug Discovery
2009
·
Naoki Tanaka
, Kazuki Ohno
, et al.
·
Journal of Chemical Information and Modeling
·
35
Advances in fragment-based drug discovery platforms
2009
·
Masaya Orita
, Masaichi Warizaya
, et al.
·
Expert Opinion on Drug Discovery
·
35
Structural characterization of mutant α-galactosidases causing Fabry disease
2008
·
Kanako Sugawara
, Kazuki Ohno
, et al.
·
Journal of Human Genetics
·
34
Mutant α-galactosidase A with M296I does not cause elevation of the plasma globotriaosylsphingosine level
2012
·
Sayuri Mitobe
, Tadayasu Togawa
, et al.
·
Molecular Genetics and Metabolism
·
32
Show more works
View as search
Works count:
74
Citation count:
1,759
H-index:
27
I10-index:
51
Year
Topic
Type